Intervention to help GPs identify and treat patients with hepatitis C found to be effective
(PHYSorg.com Medicine & Health)

The first UK clinical trial to increase the identification and treatment of hepatitis C (HCV) patients in primary care has been found to be effective, acceptable to staff and highly cost-effective for the NHS. The University of Bristol-led Hepatitis C Assessment to Treatment Trial (HepCATT), published in the British Medical Journal today, provides robust evidence of effective action GPs should take to increase HCV testing and treatment.